Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Cancer Research|August 24, 2013
Novel oncogenic PDGFRA mutations in pediatric high-grade gliomasBarbara S Paugh, Xiaoyan Zhu, Chunxu Qu, et al.Materials Science & Engineering. C, Materials for Biological Applications|July 1, 2020
Ethyl ferulate/β-cyclodextrin inclusion complex inhibits edema formationFrancisco Valmor Macedo Cunha, Gabriela do Nascimento Caldas Trindade, Pedro Simão da Silva Azevedo, et al.Cancer Discovery|March 30, 2013
Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCNLynn Bjerke, Alan Mackay, Meera Nandhabalan, et al.Therapeutic Advances in Gastroenterology|September 22, 2017
Clinical performance of an infliximab rapid quantification assayFernando Magro, Joana Afonso, Susana Lopes, et al.Nature Genetics|April 8, 2014
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine gliomaKathryn R Taylor, Alan Mackay, Nathalène Truffaux, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 23, 2019
Inhibition of neutrophil migration and reduction of oxidative stress by ethyl p-coumarate in acute and chronic inflammatory modelsAntônio Carlos Melo Lima Filho, Irismara Sousa Silva, Francisca Beatriz Melo Sousa, et al.Ebiomedicine|June 21, 2017
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic EscalationFernando Magro, Joana Afonso, Susana Lopes, et al.Therapeutic Advances in Gastroenterology|November 3, 2016
Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assaysJoana Afonso, Susana Lopes, Raquel Gonçalves, et al.Communications Biology|May 18, 2019
ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine gliomaDiana Carvalho, Kathryn R Taylor, Nagore Gene Olaciregui, et al.Scientific Reports|December 22, 2025
Navitoclax acts synergistically with irradiation to induce apoptosis in preclinical models of H3K27M-altered diffuse midline gliomaAshley Vardon, Scott Haston, Hiba Hamdi, et al.Pageof 5